Amycretin, an oral weight loss drug, led to up to 13% body weight reduction in three months, showing potential for continued ...

Amycretin, an oral weight loss pill developed by the makers of Wegovy, led to a 13.1% weight loss over three months in early ...

The highly anticipated new obesity pill shows the potential for greater and faster weight loss than Wegovy. There is a new ...

A new drug called amycretin is stepping into the spotlight, boasting impressive results that have both researchers and those ...

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...

The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...

Share on Pinterest Novo Nordisk’s new weight loss pill, amycretin, has had promising results in an early clinical trial. Image credit: SERGEI GAPON/Getty Images. Amycretin, a new weight loss ...

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that ...

Individuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, according ...

Novo Nordisk reported that its new obesity pill led to substantial weight loss in an early study, boosting the company’s ...

Amycretin, a dual pathway, oral weight loss drug, was found to be safe and tolerable in a phase 1 study and led to weight loss of up to 13% in people with overweight and obesity.

The fact that amycretin -- which appears, from early clinical data, to be as effective as injectable weight loss medications -- is taken as a pill instead of as an injection may make it more ...